Abnormal expression of CCND1 and RB1 in resection margin epithelia of lung cancer patients.

por Betticher, D. C., Heighway, J., Thatcher, N., Hasleton, P. S.
Publicado 1997

Management of bleeding in palliative care patients in the general internal medicine ward: a systematic review

por Sood, R., Mancinetti, M., Betticher, D., Cantin, B., Ebneter, A.
Publicado 2019

Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study.

por Betticher, D. C., Anderson, H., Ranson, M., Meely, K., Oster, W., Thatcher, N.
Publicado 1995

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.

por Betticher, D. C., Heighway, J., Hasleton, P. S., Altermatt, H. J., Ryder, W. D., Cerny, T., Thatcher, N.
Publicado 1996

Cladribine with cyclophosphamide and prednisone in the management of low-grade lymphoproliferative malignancies

por Laurencet, F M, Zulian, G B, Guetty-Alberto, M, Iten, P A, Betticher, D C, Alberto, P
Publicado 1999

S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas

por Smith, S L, Gugger, M, Hoban, P, Ratschiller, D, Watson, S G, Field, J K, Betticher, D C, Heighway, J
Publicado 2004

The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression

por Vonlanthen, S, Heighway, J, Altermatt, H J, Gugger, M, Kappeler, A, Borner, M M, Lohuizen, M van, Betticher, D C
Publicado 2001

Rare case of remission of a patient with small cell carcinoma of the ovary, hypercalcaemic type (SCCOHT) stage IV: Case report

por Mathey, M.P., de Jolinière, J. Bouquet, Major, A., Conrad, B., Khomsi, F., Betticher, D., Devouassoux, M., Feki, A.
Publicado 2019

p16(INK4A) as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy

por Geisler, S, Smith-Sørensen, B, Betticher, D, Bukholm, IK, Akslen, LA, Kappeler, A, Gugger, M, Lønning, PE, Børresen-Dale, A-L
Publicado 2000

Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instabili...

por Smith, S L, Bowers, N L, Betticher, D C, Gautschi, O, Ratschiller, D, Hoban, P R, Booton, R, Santibáñez-Koref, M F, Heighway, J
Publicado 2005

Two Case Reports of a Malignant Germ Cell Tumor of Ovary and a Granulosa Cell Tumor: Interest of Tumoral Immunochemistry in the Identification and Management

por Bouquet de Jolinière, J., Ben Ali, N., Fadhlaoui, A., Dubuisson, J. B., Guillou, L., Sutter, A., Betticher, D., Hoogewoud, H. M., Feki, A.
Publicado 2014

Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer

por Borner, M M, Brousset, P, Pfanner-Meyer, B, Bacchi, M, Vonlanthen, S, Hotz, M A, Altermatt, H J, Schlaifer, D, Reed, J C, Betticher, D C
Publicado 1999

High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressor.

por White, G. R., Stack, M., Santibáñez-Koref, M., Liscia, D. S., Venesio, T., Wang, J. C., Helms, C., Donis-Keller, H., Betticher, D. C., Altermatt, H. J., Hoban, P. R., Heighway, J.
Publicado 1996

LBA80 Outcome and prognostic factors of SARS CoV-2 infection in cancer patients: A cross-sectional study (SAKK 80/20 CaSA)

por Joerger, M., Metaxas, Y., Schmitt, A., Koeberle, D., Zaman, K., Betticher, D., Mach, N., Renner, C., Mark, M.T., Petrausch, U., Caspar, C.B., Britschgi, C., Taverna, C., Zenger, F., Mingrone, W., Schulz, J., Kopp, C., Hayoz, S., Stathis, A., von Moos, R.
Publicado 2020

1570P Outcome and prognostic factors of COVID-19 infection in cancer patients: Final results of SAKK 80/20

por Joerger, M., Metaxas, Y., Zaman, K., Michielin, O.A., Mach, N., Betticher, D., Schmitt, A.M., Cantoni, N., Caspar, C.B., Stettler, S., Malval, R., Pless, M., Britschgi, C., Renner, C., Koeberle, D., Schulz, J., Kopp, C., Hayoz, S., Stathis, A., von Moos, R.
Publicado 2021

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study

por Betticher, D C, Hsu Schmitz, S-F, Tötsch, M, Hansen, E, Joss, C, von Briel, C, Schmid, R A, Pless, M, Habicht, J, Roth, A D, Spiliopoulos, A, Stahel, R, Weder, W, Stupp, R, Egli, F, Furrer, M, Honegger, H, Wernli, M, Cerny, T, Ris, H-B
Publicado 2006

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials

por König, D., Schär, S., Vuong, D., Guckenberger, M., Furrer, K., Opitz, I., Weder, W., Rothschild, S.I., Ochsenbein, A., Zippelius, A., Addeo, A., Mark, M., Eboulet, E.I., Hayoz, S., Thierstein, S., Betticher, D.C., Ris, H.-B., Stupp, R., Curioni-Fontecedro, A., Peters, S., Pless, M., Früh, M.
Publicado 2022

Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/0...

por König, D., Savic Prince, S., Hayoz, S., Zens, P., Berezowska, S., Jochum, W., Stauffer, E., Braunersreuther, V., Trachsel, B., Thierstein, S., Mark, M., Schmid, S., Curioni-Fontecedro, A., Addeo, A., Opitz, I., Guckenberger, M., Früh, M., Betticher, D.C., Ris, H.-B., Stupp, R., Rothschild, S.I., Bubendorf, L., Pless, M.
Publicado 2023